Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PPH

VanEck Pharmaceutical ETF

Nov 03 • 04:00PM ET

92.84

+0.30 0.32 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	2.01%	Total Holdings	27	Perf Week	0.31%
Sponsor	Van Eck Associates Corporation	ETF Type		Tags	equity	Return% 3Y	10.64%	AUM	1.18B	Perf Month	-1.29%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	10.43%	NAV/sh		Perf Quarter	8.71%
Index	MVIS US Listed Pharmaceutical 25 Index	Average Maturity		Tags	pharmaceutical	Return% 10Y		52W High	95.13 -2.41%	Perf Half Y	4.76%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	77.67 19.53%	Perf YTD	7.60%
Active/Passive		Quant Type		Tags	-	Flows% 1M	70.69%	Volatility	1.32% 1.06%	Perf Year	1.01%
Dividend TTM	1.94 (2.08%)	ESG Type		Tags	-	Flows% 3M	119.03%	ATR (14)	1.10	Perf 3Y	28.84%
Dividend Ex-Date	Oct 01, 2025	Dividend Type		Sector/Theme		Flows% YTD	88.40%	RSI (14)	58.65	Perf 5Y	52.85%
Dividend Gr. 3/5Y	10.99% 8.51%	Structure Type		Region		Flows% 1Y		Beta	0.49	Perf 10Y	45.75%
Expense	0.36%	Growth/Value		SMA20	0.57%	Flows% 3Y		Rel Volume	0.74	Prev Close	92.54
Inverse/Leveraged		Market Cap		SMA50	2.56%	Flows% 5Y		Avg Volume	530.54K	Price	92.84
IPO	Dec 21, 2011	Option/Short	Yes / Yes	SMA200	4.66%	Trades		Volume	397,560	Change	0.32%

Oct-16-25 03:14AM	Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? (Insider Monkey)
Oct-13-25 06:10AM	Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? (Motley Fool)
Oct-10-25 06:09PM	AstraZeneca becomes latest drugmaker to strike deal with Trump. Its stock is climbing after hours. (MarketWatch)
Oct-06-25 06:57AM	4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio (Zacks)
Oct-01-25 11:10AM	Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End (Barrons.com)
01:05PM	Loading…
Sep-26-25 01:05PM	Pharma stocks gain, as Trump's tariff move actually could be a win for the sector (MarketWatch)
09:24AM	Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit (Zacks)
Sep-22-25 06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
Aug-19-25 06:15AM	NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain (Zacks)
Aug-08-25 11:00AM	ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data (Zacks)
Jul-22-25 06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
Jul-17-25 11:00AM	ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook (Zacks)
Jul-01-25 06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
Jun-18-25 06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
May-21-25 06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
10:00AM	Loading…
May-15-25 10:00AM	ETFs to Capitalize on the Novo Nordisk-Septerna Deal (Zacks)
May-13-25 08:00AM	PPH, Big Pharma Stocks Volatile on Trump Drug Pricing (etf.com)
May-12-25 12:52PM	ETFs on the Move Post U.S.-China Trade Deal (Zacks)
10:30AM	Pharma ETFs in Focus on Trump's Drug Price Overhaul (Zacks)
May-09-25 06:20AM	Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? (Zacks)
May-08-25 11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-28-25 06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-17-25 06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
Apr-16-25 10:00AM	ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike (Zacks)
Apr-14-25 09:15AM	PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.62%
07:00AM	Loading…
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
Dec-20-24 08:56PM	VanEck Announces Year-End Distributions for VanEck Equity ETFs (Business Wire)
Sep-20-22 03:13PM	Best Pharmaceutical ETFs for Q4 2022 (Investopedia)
Mar-26-22 10:00PM	When Should You Buy Pushpay Holdings Limited (NZSE:PPH)? (Simply Wall St.)
Jan-24-22 01:38PM	Altfest L J & Co Inc Buys iShares 0-5 Year TIPS Bond ETF, ISHARES TRUST, iShares U.S. ... (GuruFocus.com)
Dec-14-21 10:38PM	VanEck Africa Index ETF Buys Helios Towers PLC, Capitec Bank Holdings, First Quantum Minerals, ... (GuruFocus.com)
May-22-20 07:46AM	Telehealth is going to 'become the default' for patients: Ro CEO (Yahoo Finance)
May-18-20 10:03AM	3 ETFs in Focus as Race for Vaccine Intensifies (Investopedia)
Apr-09-20 10:10AM	Top-Ranked ETFs & Stocks to Buy From Bargain Industries (Zacks)
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Jan-22-20 01:00PM	Sector ETFs & Stocks to Gain/Lose on Coronavirus Outbreak (Zacks)
Dec-20-19 08:10AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-05-19 03:34PM	Hedge Funds Are Warming Up To GlaxoSmithKline plc (GSK) (Insider Monkey)
Nov-22-19 05:15PM	VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors ETFs (Business Wire)
Nov-08-19 08:00AM	Pharma Sector Tops in October: Best ETFs & Stocks (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
Sep-30-19 06:04PM	Announcing VanEck Vectors ETFs September 2019 Distributions (Business Wire)
Sep-23-19 11:27AM	Pharma ETFs Boosted After Senate Rejects House Drug Pricing Plan (ETF Trends)
Sep-09-19 02:09PM	10 ETFs That Could Be Primed For A Short Squeeze (Benzinga)
Aug-22-19 11:12AM	8 ETFs to Capture Opportunities in Healthcare Sector (ETF Trends)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
Jun-28-19 06:01PM	Announcing VanEck Vectors ETFs June 2019 Distributions (Business Wire)
Jun-26-19 11:00AM	AbbVie to Buy Allergan: Prescribed ETFs (Zacks)
Jun-25-19 06:01PM	AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs (ETF Trends)
May-14-19 05:40PM	Legal Troubles Beset Pharmaceutical Sector ETFs (ETF Trends)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
Apr-30-19 12:59PM	Disruptive GW Pharmaceuticals Is Exempt from Big Pharmas Volatility (InvestorPlace)
Mar-29-19 06:42PM	Announcing VanEck Vectors ETFs March 2019 Distributions (Business Wire)
Mar-21-19 07:56AM	Does Recent Weakness in AbbVie Stock Make It a Buy? 3 Pros, 3 Cons (InvestorPlace)
Feb-21-19 10:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-29-19 09:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-07-19 09:27AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-26-18 06:37PM	Announcing VanEck Vectors Equity ETFs December 2018 Distribution (Business Wire)
Dec-14-18 09:28AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Dec-10-18 10:33AM	Dont Punish Gilead Stock for Doing Its Job (InvestorPlace)
Nov-16-18 05:52PM	VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors Equity ETFs (Business Wire)
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections (Zacks)
Oct-17-18 11:48AM	VanEck Launches ESPO, ETF Focused on Fast Growing Video Game and eSports Industry (Business Wire)
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 (Investopedia)
Oct-09-18 11:39AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Sep-28-18 06:03PM	Announcing VanEck Vectors Equity ETFs September 2018 Distributions (Business Wire)
Jul-03-18 03:19PM	July Could Be a Volatile Month for Pharma ETFs (ETF Trends)
Jun-29-18 06:15PM	Announcing VanEck Vectors Equity ETFs June 2018 Distributions (Business Wire)
Jun-04-18 10:38AM	Biogen Inc Stock Got an Upgrade, but Should You Listen? (InvestorPlace)
Apr-24-18 06:41AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Mar-29-18 05:58PM	Announcing VanEck Vectors Equity ETFs March 2018 Distributions (Business Wire)
Jan-25-18 09:00AM	Tasigna Could Boost Novartiss Revenue Growth in 2018 (Market Realist)
07:31AM	Novartis Receives 2 Breakthrough Therapy Designations in January (Market Realist)
Jan-22-18 10:00AM	Behind Novartiss 4Q17 Earnings: Why Some Expect Revenue Growth (Market Realist)
07:34AM	Johnson & Johnsons Consumer Segment: 4Q17 Estimates (Market Realist)
Jan-15-18 10:31AM	How Teva Pharmaceutical Is Realigning Organizational Structure (Market Realist)
Jan-10-18 12:03PM	Mylans Valuation in January 2018 (Market Realist)
Jan-09-18 10:31AM	Valeant on the Street: Analyst Recommendations in December 2017 (Market Realist)
Jan-08-18 07:33AM	How Did Novo Nordisks NovoMix and Human Insulin Perform in 2017? (Market Realist)
Jan-05-18 10:35AM	How Novo Nordisks Biopharmaceuticals Segment Performed in 3Q17 (Market Realist)
Dec-26-17 06:15PM	Announcing VanEck Vectors Equity ETFs December 2017 Distributions (Business Wire)
Nov-22-17 05:30PM	VanEck Announces Preliminary Yearend Distribution Estimates for VanEck Vectors Equity ETFs (Business Wire)
Nov-14-17 02:35PM	Understanding Sanofis Revenues by Segment in 3Q17 (Market Realist)
Oct-16-17 12:33PM	President Trump reiterates that drug companies 'getting away with murder' but says not much else (MarketWatch)
Oct-02-17 12:35PM	CORRECTING and REPLACING Announcing VanEck Vectors Equity ETFs September 2017 Distributions (Business Wire)
Sep-29-17 05:25PM	Announcing VanEck Vectors Equity ETFs September 2017 Distributions (Business Wire)
Sep-20-17 10:36AM	Why Cosentyx Could Significantly Drive Novartiss Revenue Growth (Market Realist)
Sep-19-17 10:38AM	An Update on Novartiss Sandostatin, Afinitor, and Exjade (Market Realist)
Sep-14-17 07:39AM	TEVA Depends on This for Revenue Growth (Market Realist)

VanEck Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

open in yahoo | open in marketwatch | open in google

PPH

VanEck Pharmaceutical ETF

Upgrade your FINVIZ experience